GUTS Q1 2024 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

GUTSFractyl Health, Inc. Common Stock

$35M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$33,000+560.0% YoY

Gross Profit

$14,00042.4% margin

Operating Income

-$22M-65278.8% margin

Net Income

-$3M-10066.7% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+371.4%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$164M

Total Liabilities

$79M

Stockholders' Equity

$84M

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33,000	$5,000	+560.0%
Gross Profit	$14,000	$2,000	+600.0%
Operating Income	-$22M	-$12M	-77.9%
Net Income	-$3M	-$12M	+72.2%